AYAlla V. Yurenko

Alla V. Yurenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alla V. Yurenko has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Marina V. Antonyuk

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    11 shared publications
  • Elena Evgenievna Mineeva

    Vladivostok Branch of the Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Scientific Research Institute of Medical Climatology and Rehabilitation Treatment

    10 shared publications
  • Tatyana A. Gvozdenko

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    5 shared publications
  • Tatyana P. Novgorodtseva

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    3 shared publications
  • A. A. Uksumenko

    Far Eastern Scientific Center of Physiology of Respiration

    2 shared publications
  • K. K. Khodosova

    Research Institute of Medical Climatology and Rehabilitation Treatment, Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration

    2 shared publications

Latest Publications

  • Open Access

    On the diagnosis of smallairway dysfunction in mild asthma

    by А. V. Yurenko, М. V. Аntonyuk, Е. Е. Мineeva

    Aim. To assess the functional status of the small airways by bodyplethysmography and to determine the degree of small-airway dysfunction (SAD) in patients with mild asthma.Materials and methods. We examined 191 patients with mild asthma. The control group consisted of 36 healthy volunteers. Using bodyplethysmography, we evaluated functional residual capacity (FRC), residual volume (RV), total lung capacity (TLC) and the RV/TLC ratio. SAD was defined as RV > 140% predicted, RV/TLC > 125% predicted or FRC > 130% predicted. The severity of SAD was graded by percentage deviation from predicted values and z-scores.Results. SAD was detected in 44 asthma patients. Cluster analysis based on RV, RV/TLC and FRC divided these patients into three clusters. Statistically significant differences between clusters were found for RV, RV/TLC and their z-scores. Cluster 1 was characterised by elevated RV and RV/TLC. In Cluster 2, compared with Cluster 1, high RV and RV/TLC were accompanied by an FRC increase in 50% of cases. Cluster 3 showed high RV, RV/TLC and FRC, along with a TLC increase in 55% of cases. Spirometry demonstrated a progressive decline in airway patency, reflected by reduced FEV1 and maximum expiratory flow rates (MEF); worsening obstruction resulted in reduced VC in Clusters 2 and 3. SAD was consistently accompanied by elevated RV and RV/TLC, indicating marked air-trapping.Conclusion. SAD occurred in 23% of patients with mild asthma and was accompanied by a pronounced decrease in indices characteristic of bronchial-obstructive syndrome, including distal airways. RV, RV/TLC and their z-scores constitute the primary criteria for grading SAD in this patient population.

  • Open Access

    Small airway dysfunction in asthma: diagnostic, pathogenetic and therapeutic aspects

    by А. V. Yurenko

    In recent years, increasing attention has been paid to the role of the small airways (SA) in the pathophysiological and clinical aspects of asthma. The article summarizes the main methods for assessing impaired SA function—spirometry, body plethysmography, impulse oscillometry, fractional exhaled-nitric-oxide analysis, inert-gas washout tests and computed tomography—and notes the absence of a single standard technique for identifying SA dysfunction. The pathogenetic mechanisms underlying SA dysfunction in asthma are discussed, with an emphasis on the key roles of cytokines, eicosanoids (polyunsaturated-fatty-acid metabolites) and plasmalogens in the complex network of mediators that regulate chronic airway inflammation. The potential for correcting SA dysfunction with modern pharmacological agents aimed at restoring lung function is considered. The studies analyzed highlight the importance of early evaluation of SA status and identification of triggers that drive SA dysfunction in asthma.


  • Open Access

    Lung function in patients with asthma in the post-COVID period

    by E. E. Mineeva, M. V. Antonyuk, A. V. Yurenko

    Aim. To assess the lung function in patients with bronchial asthma (BA) after new-onset coronavirus infection.Materials and methods. Fifty-five patients who underwent COVID-19 participated in the study under conditions of voluntary informed consent. The main group consisted of 30 patients with mild BA, the comparison group – 25 patients without chronic respiratory diseases (CRD). According to chest computed tomography (CT) findings, the degree of lung parenchyma involvement was classified as follows: mild COVID-19 (CT 0 stage) in 14 patients; moderate COVID-19 (CT 1-2 stages) in 27 patients; and severe COVID-19 (CT 3-4 stages) in 14 patients. Lung function tests were conducted once, adhering to both Russian and international standards.Results. In patients with BA, obstructive pulmonary function impairment was predominant at CT 1-2 stages (79%), CT 0 stage (67%), and CT 3-4 stages (43%). Lung diffusion capacity (LDC) was impaired predominantly in CT 3-4 stages in both BA patients and those without CRD, occurring in 57% of cases. Analysis of lung function showed that LDC reduction was detected in 17% of BA cases and 24% of non-CRD cases. There were no statistically significant changes in pulmonary ventilation among BA patients with impaired LDC compared to patients without CRD.Conclusion. All patients with respiratory symptoms after COVID-19 should undergo comprehensive lung function assessment to identify bronchial obstruction, impaired lung diffusion capacity, and ensure timely intervention.

  • Open Access

    1-O-alkyl-glycerols from Squid Berryteuthis magister Reduce Inflammation and Modify Fatty Acid and Plasmalogen Metabolism in Asthma Associated with Obesity

    by Yulia Denisenko, Tatyana Novgorodtseva, Marina Antonyuk, Alla Yurenko, Tatyana Gvozdenko, Sergey Kasyanov, Ekaterina Ermolenko, Ruslan Sultanov

    Asthma associated with obesity is considered the most severe phenotype and can be challenging to manage with standard medications. Marine-derived 1-O-alkyl-glycerols (AGs), as precursors for plasmalogen synthesis, have high biological activity, making them a promising substance for pharmacology. This study aimed to investigate the effect of AGs from squid Berryteuthis magister on lung function, fatty acid and plasmalogen levels, and cytokine and adipokine production in obese patients with asthma. The investigational trial included 19 patients with mild asthma associated with obesity who received 0.4 g of AGs daily for three months in addition to their standard treatment. The effects of AGs were evaluated at one and three months of treatment. The results of the study demonstrated that intake of AGs increased the FEV1 and FEV1/VC ratios, and significantly decreased the ACQ score in 17 of the 19 patients after three months of treatment. The intake of AGs increased concentration of plasmalogen and n–3 PUFA in plasma, and modified leptin/adiponectin production by adipose tissue. The supplementation of AGs decreased the plasma levels of inflammatory cytokines (TNF-α, IL-4, and IL-17a), and oxylipins (TXB2 and LTB4), suggesting an anti-inflammatory property of AGs. In conclusion, 1-O-alkyl-glycerols could be a promising dietary supplement for improving pulmonary function and reducing inflammation in obese asthma patients, and a natural source for plasmalogen synthesis. The study highlighted that the beneficial effects of AG consumption can be observed after one month of treatment, with gradual improvement after three months of supplementation.


  • Open Access

    The role of fatty acids and lipid inflammatory mediators in the development of small airway dysfunction in asthma complicated with obesity

    by A. V. Yurenko, T. P. Novgorodtseva, Yu. K. Denisenko, M. V. Antonyuk, E. E. Mineeva

    Background. Small airway involvement is important in determining the phenotypes of bronchial asthma. Establishing the mechanisms of dysfunction of small airways will make it possible to predict the course and control bronchial asthma.The aim. To study the relationship between the modification of the composition of fatty acids, lipid inflammatory mediators (eicosanoids, plasmalogens) and the functional state of small airways and to identify lipid biomarkers for the development of small airway dysfunction in bronchial asthma associated with obesity.Materials and methods. The study included 85 patients with mild, partially controlled asthma. Of these, 39 patients with normal body weight (Group 1) and 46 patients with grade 1–2 obesity (Group 2). The control group consisted of 30 healthy volunteers. The function of the small airways was assessed according to spirometry and body plethysmography. The composition of fatty acids and plasmalogens in blood plasma was assessed by gas chromatography-mass spectrometry. In the blood serum, the content of thromboxane B2 and leukotriene B4 was determined. Statistical processing was performed using the Statistica 6.1 program (StatSoft Inc., USA). Relationships between pairs of traits were examined using the Spearman correlation test (r). Differences were considered statistically significant at p < 0.05.Results. In the combined course of asthma and obesity, dysfunction of the small airways develops against the background of generalized bronchial obstruction. A violation of lipid metabolism was revealed, manifested by an increase in the levels of saturated, monoenoic, n-6 polyunsaturated fatty acids against the background of a deficiency of n-3 polyunsaturated fatty acids and phospholipids with an alkenyl bond – plasmalogens. It has been shown that bronchial asthma, aggravated by obesity, occurs against the background of increased synthesis of inflammatory lipid mediators – eicosanoids (thromboxane B2 and leukotriene B4). Evaluation of the correlation relationships between the studied lipids and the function of small airways revealed a high degree of relationship between their participants.Conclusion. An important pathogenetic link in the formation of small airway dysfunction in bronchial asthma aggravated by obesity is a violation of fatty acid metabolism and plasmalogen synthesis, an increase in the formation of inflammatory lipid mediators.


  • Open Access

    Pathophysiological relation between the systemic inflammation and the state of small airways in mild asthma with obesity

    by A. V. Yurenko, M. V. Antonyuk, E. E. Mineeva, K. K. Khodosova

    Цель исследования – установить взаимосвязи между уровнем цитокинов в сыворотке крови и показателями легочной функции; выделение маркеров развития дисфункции малых дыхательных путей у больных легкой бронхиальной астмой частично контролируемого течения с ожирением. Обследовано 53 пациента с легкой бронхиальной астмой частично контролируемого течения с ожирением I-II степени. Группу контроля составили 25 здоровых добровольцев. Всем участникам проводили спирометрию, бодиплетизмографию, в сыворотке крови определяли фактор некроза опухоли альфа (TNFα), интерферон гамма (IFNγ), интерлейкины (IL) IL-2, IL-4, IL-6, IL-10, IL-17А. У пациентов с бронхиальной астмой легкой степени тяжести частично контролируемого течения независимо от массы тела выявлено увеличение IL-17А на 55,8% и IL-4 на 44,9%. По результатам кластерного анализа выделено две группы в зависимости от состояния малых дыхательных путей и уровня про- и противоспалительных цитокинов. Показано, что дисфункция малых дыхательных путей сопровождается гиперцитокинемией и чаще диагностируется при бронхиальной астме с преобладанием Th1- и Th17-иммунного ответа. Выявлена ассоциация IL-17А, IL-6 с показателями, отражающими состояние малых дыхательных путей, IFNγ с показателями, указывающими на наличие обструкции. При легкой бронхиальной астме с ожирением выявлены особенности легочной функции в зависимости от цитокинового статуса. Выделено два иммуно-функциональных варианта, отличающиеся активностью системного воспаления, типом иммунного ответа и состоянием малых дыхательных путей. Выявленные взаимосвязи позволяют рассматривать IL-17А, IL-6 и IFNγ как маркеры дисфункции малых дыхательных путей при легкой бронхиальной астме частично контролируемого течения, ассоциированной с ожирением.


  • Open Access

    Association between the clinical-functional parameters and lipid markers of systemic inflammation in mild asthma complicated with obesity

    by A. A. Uksumenko, M. V. Antonyuk, Yu. K. Denisenko, A. V. Yurenko, E. E. Mineeva

    Aim. To identify the features of the association between the clinical-functional conditions and lipid markers of systemic inflammation (fatty acids, eicosanoids, plasmalogens) of patients with mild asthma and obesity. Materials and methods. Obese (n=80) and nonobese (n = 55) adults with mild, partially controlled asthma aged 28 to 65 years, and nonobese (n = 30) healthy controls had venous blood samples analysed. The ACQ-5 test, spirometry were evaluated. Serum thromboxane B2 (ТХВ2) and leukotriene B4 (LTB4) were analyzed by the enzyme immunoassay method. Fatty acidsas methyl esters (FAMEs) and plasmalogens in the form of dimethyl acetals (DMA) were estimated in blood plasma by gas chromatography-mass spectrometry. Results. In obese patients with asthma, the ACQ-5 test was lower in comparison to nonobese patients. FEV1 decreased by 8 %, FVC by 12% (p < 0.05). A decrease in the level of DMA16: 0 by 17.5 % and DMA18: 0 by 25 % was established in obese asthma patients. The ratio of DMA16:0/FAME 16: 0 declined by 21 %, DMA18:0/FAME18: 0 − by 28 %. A fall in eicosapentaenoic acid (20: 5n3) and a change in the 20:4n6/20:5n3 ratio were found. The level of ТХВ2 and LTB4 was increased regardless of body weight. There was a positive correlation between body mass index and levels of LTB4 (r = 0.46), ТХВ2 (r = 0.49); and a negative correlation between ACQ and ТХВ2 (r = - 0.58). Indicators of lung function (FEV1, FVC, VC) had correlative links with DMA18:0, DMA20:0, eicosapentaenoic acid. Conclusion. We showed the change in the inflammatory fatty acids and eicosanoids synthesis and plasmalogen deficiency in obese-asthma. Established relationships between clinical and functional parameters and lipid markers of systemic inflammation, plasmalogen deficiency in patients with asthma and obesity reveal new pathogenetic mechanisms of the systemic inflammatory process in chronic respiratory diseases.


  • Open Access

    Predictors of dysfunction of the small respiratory tract in patients with asthma

    by Alla V. Yurenko, Marina V. Antonyuk, Elena E. Mineeva, Tatyana A. Gvozdenko

    Aim. To identify predictors of development of small respiratory tract (SRT) dysfunction in patients with asthma of mild severity, partially controlled course. Materials and methods. One hundred and fourteen patients with asthma of mild severity, partially controlled course, were examined. The control group consisted of 27 healthy volunteers. The main risk factors for the development of AD were revealed by questioning in all patients, an ACQ-5 test was used to determine the level of disease control, functional research was carried out using spirography and bodyplethysmography methods. To assess the relative risk, the odds ratio calculation was used. Results. 55% of all examined patients with asthma indicated 3 or more risk factors. Bronchial obstruction occurred in 26.3% of cases. According to the functional examination, patients are divided into 2 groups: 94 patients without dysfunction of the SRT and 20 patients with dysfunction of the SRT (17.5% of cases). The significance of differences in the development of dysfunction of the SRT depending on the impact of the risk factor between groups of patients was assessed. Among the traditional risk factors for asthma, the most negatively affecting the development of dysfunction of the SRT in patients were identified. It has been established that the duration of asthma disease for more than 5 years, the symptoms of bronchial obstruction diagnosed in patients increase the risk of dysfunction of the SRT by 4.95 and 4.83 times, respectively, the presence of extrapulmonary allergic diseases, namely allergic rhinitis by 4.31 times, urticaria 3.58 times. Conclusion. It has been shown that the most significant factors affecting the occurrence of dysfunction of the SRT in patients with asthma of mild severity are the duration of asthma for more than 5 years, the presence of extrapulmonary allergic diseases in patients (allergic rhinitis and urticaria) and bronchial obstruction in patients.


  • Open Access

    Features of immune response in different phenotypes of chronic obstructive pulmonary disease

    by M. V. Antonyuk, E. E. Mineeva, V. V. Knyshova, A. V. Urenko, T. I. Vitkina, T. P. Novgorodtseva, T. A. Gvozdenko

    Chronic obstructive pulmonary disease (COPD) is considered a heterogeneous disorder exhibiting different phenotypes. Chronic systemic inflammation is an important link in the COPD pathogenesis. The studies of immune response in the context of clinical and functional phenotypes seems relevant. Objective of our work was to study the features of immune response in clinical and functional phenotypes of COPD.Eighty-three COPD patients of different severity grade and 22 apparently healthy volunteers were examined. After determining the COPD phenotype by clinical and functional signs, the patients were divided in two groups, i.e., 38 subjects with bronchitis, and 45 patients with emphysematous phenotype. Clinical, functional and laboratory research was carried out in standard mode. Static lung volumes and respiratory capacities were investigated, i.e., functional residual capacity, residual lung volume, total lung capacity, bronchial resistance on inspiration and expiration to assess phenotype of the disease. Subpopulations of Th1 and Th17 lymphocytes were determined by the level of blood serum cytokines, tumor necrosis factor (TNFá), interleukins (IL) IL-4, IL-10, IL-17A, IFNã).Different features of immune response were revealed in bronchitic and emphysematous phenotypes of the COPD patients. Activation of inflammatory process with differentiation of naive T lymphocytes along the Th1-dependent pathway was found in 68% of cases with bronchitis and 16% of patients with emphysematous phenotypes. As compared with control group, the patients showed a statistically significant increase in the level of TNFá, IFNã, along with decrease in IL-4. Development of immune response by the Th17 type was found in 32% of cases with bronchitis, and 84% of cases with emphysematous phenotypes. Its emergence was associated with increased IL-17A and IL-10 levels, and a decrease in IFNã/IL-17A compared to the control. Differentiation of T helper cells towards Th1 pathway of immune response has been shown to predominate in bronchitic phenotype and at early stages of the disease. The Th17 type of immune response prevailed with increasing severity of the disorder. In emphysematous phenotype of COPD, the Th17-pathway of immune response develops at early stages of the disease. Some relationships are revealed between the systemic inflammation indexes and functional parameters of external respiration. An inverse relationship between TNFá and the OOL/OEL ratio in Th1 type of immune response has been shown. A direct correlation was found between the level of IL-17A and the parameters of external respiration function (FEV1, FEV1/FVC), as well as between IFNã/IL-17A and functional residual capacity in Th17 type of immune response.The type of immune response is associated with severity of the disease, as well with clinical and functional phenotype of COPD. Progression of the disease, broncho-obstructive disorders and hyperinflation are associated with increased levels of cytokines that provide cell polarization along the Th17 pathway. Determination of COPD phenotype and the type of immune response already at an early stage of the disease will enable prediction of its course and justify the choice of phenotype-oriented therapy.


  • Open Access

    Clinical and immunological efficiency of dry carbon dioxide baths in patients with asthma and obesity at the ambulatory-polyclinic stage of rehabilitation

    by A. A. Uksumenko, M. V. Аntonyuk, E. E. Мineeva, A. V. Yurenko, K. K. Khodosova

    Introduction. An important part in the rehabilitation treatment of patients with asthma associated with obesity is the ambulatory-polyclinic stage of rehabilitation that includes drug and physiotherapeutic treatment. Recently, dry carbon dioxide baths (DCDB) are increasingly used.Aim. is to assess the clinical and immunological efficiency of DCDB in the complex rehabilitation treatment of patients with asthma and obesity at the ambulatory-polyclinic stage of rehabilitation.Materials and methods. The study included 60 patients with asthma and obesity admitted to the departments of medical rehabilitation and clinical examination of scientists of the Medical Association of FEB RAS. Patients of the main group (30 subjects) received DCDB and drug therapy. Patients of the comparison group (30 subjects) received only drug therapy. The DCDB procedures were carried out using the “Reabox” device at CO2 concentration of 15-20%, a temperature of 28-30ºC, 10 procedures. The changes in symptoms, ACQ-5 test, and respiratory function were assessed. The parameters of cellular immunity CD3+, CD4+, CD8+, CD16+, CD19+ and the levels of tumor necrosis factor (TNFα), interleukins (IL) IL-2, IL-4, IL-6, IL-10, IL-17A in the blood were analyzed.Results. The achievement of asthma control took less time in patients of the main group. The improvement of bronchial patency was evidenced by the positive dynamics of spirometric indices. After DCDB therapy, an increase in suppressive activity of the cellular immunity, a decrease in the levels of pro-inflammatory cytokine IL-4, IL-17A were revealed. The TNF-α/IL-10 ratio statistically significantly changed due to the increase in the level of anti-inflammatory cytokine IL-10. In the comparison group, the positive dynamics was less pronounced.Conclusion. The use of DCDB increases the clinical and immunological efficiency of the rehabilitation of patients with asthma and obesity at the ambulatory-polyclinic stage. The clinical effect is associated with immunocorrective action, which allows achieving control of the disease in a shorter period of time.